tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 373 are a BUY (96.38%), 13 are a HOLD (3.36%), 1 are a SELL (0.26%).
Analyst Jason Butler, carries an average stock price target met ratio of 36% that have a potential upside of 55.43% achieved within 211 days. Previously, Jason Butler worked at JMP.
Jason Butler’s has documented 734 price targets and ratings displayed on 52 stocks. The coverage was on Healthcare, Industrials, Consumer Cyclical, Technology sectors.
Most recent stock forecast was given on HALO, Halozyme Therapeutics.
Analyst best performing recommendations are on ABVX (ABIVAX SA).
The best stock recommendation documented was for ABVX (ABIVAX SA) at 7/14/2025. The price target of $33 was fulfilled within 9 days with a profit of $24.17 (273.73%) receiving and performance score of 304.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jun-2022
$38
$16.53 (76.99%)
$36
Buy Since 23-Jun-2025
$38
$16.53 (76.99%)
$36
Buy Since 28-Feb-2024
$35
$13.53 (63.02%)
$35
21 days ago
(19-Oct-2026)
9/16 (56.25%)
$15.2 (76.77%)
393
Buy Since 15-Dec-2025
$33
$11.53 (53.70%)
$37
1 months 15 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$12.53 (58.36%)
$36
1 months 15 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Which stock is Jason Butler most bullish on?
Which stock is Jason Butler most reserved on?
